[5]. National Institute of Health and Care Excellence (NICE).Multimorbidity: clinical assessment and management. NICE, 2016, NICE guideline NG56. [6]. Eur Heart J.2022 Sep 7;43(34):3213-3223. [7]. National Institute for H...
[5]. National Institute of Health and Care Excellence (NICE).Multimorbidity: clinical assessment and management. NICE, 2016, NICE guideline NG56. [6]. Eur Heart J.2022 Sep 7;43(34):3213-3223. [7]. National Institute for Health and Care Excellence.Ezetimibe for treating primary heterozygous...
[5]. National Institute of Health and Care Excellence (NICE).Multimorbidity: clinical assessment and management. NICE, 2016, NICE guideline NG56. [6]. Eur Heart J.2022 Sep 7;43(34):3213-3223. [7]. National Institute for Health and Care Excellence.Ezetimibe for treating primary heterozygous...
[5]. National Institute of Health and Care Excellence (NICE).Multimorbidity: clinical assessment and management. NICE, 2016, NICE guideline NG56. [6]. Eur Heart J.2022 Sep 7;43(34):3213-3223. [7]. National Institute for Health and Care Excellence.Ezetimibe for treating primary heterozygous...
[5]. National Institute of Health and Care Excellence (NICE).Multimorbidity: clinical assessment and management. NICE, 2016, NICE guideline NG56. [6]. Eur Heart J.2022 Sep 7;43(34):3213-3223. [7]. National Institute for Health and Care Excellence.Ezetimibe for treating primary heterozygous...
Its acute coronary syndromes (ACS) guideline is expected to address risk stratification for triage and management purposes.Rachel O’MahonyPrimary Health Care
The first is for patients with acute chest pain who may have an ACS and the second for those with intermittent stable chest pain who may have stable angina. The guideline deals with chest pain of suspected cardiac origin. Thus, for example, the guideline does not apply to patients with ...
A Senthinathan,V Kelly,M DzinginaD JonesM BakerD Longson On behalf of the Guideline Development Group - 《Bmj British Medical Journal》 被引量: 0发表: 2011年 Managing hyperglycaemia in acute coronary syndrome (ACS): experience from a London hospital Aim Hyperglycaemia at the time of admission...
(CBmodel) find it difficult to accept this paradigm shift. In, for example, an article inThe Lancet, they try to argue that the new NICE guideline is based on ideology instead of science. In this article we reviewed the evidence they used to support their claims. Our analysis shows that...
All women were asked to test their blood glucose six times a day on at least 3 days of the week, as per the local guideline: fasting, 1-h post-breakfast, pre-lunch, 1-h post-lunch, pre-dinner, and 1-h post-dinner. The target blood glucose range was fasting BG readings ≥3.5 mm...